| Support Real Science in Autism Treatment! |
My student Molly is nonvocal. Whenever I assign independent worksheets, Molly will often refuse to work by ripping up the assignment, throwing her pencil, or putting her head down. There are also times when the students are working and I have to take a phone call or am helping another student, and she screams. I…
Dear Mr. Ellis, Thank you kindly for your recent article Early Death in Those with Autism Spectrum Disorder. As you aptly stated in your piece, you anticipated that sharing these studies would shock your readers. We also hope that it motivates the autism community to reflect carefully on what we are doing (and what we are…
Dear EurekAlert: Thank you for your article which suggested that children with autism spectrum disorder (ASD) were nearly 2.5 times more likely than children without ASD to be reported for suspected abuse/neglect by the age of 8. These data support other troubling statistics regarding the risks facing children with ASD, including higher mortality rates and…
Thank you, Liam Davenport, for your February 25th article, “Unproven Therapies are ‘Muddying’ Cell and Gene Advances” in Medscape. Although it was published several months ago, the content is well worth sharing with our readers. Your article shines a light on yet another example of the “cart before the horse,” where treatments are marketed…
Dear Ms. Barloso, Thank you for your recent article showcasing various interventions for autism for children with autism based on the time-tested and scientifically-validated principles of applied behavior analysis (ABA). A common denominator among these approaches is that each enjoys scientific support and rely on data to make important decisions. At present, there are over 500 different…
David Celiberti, PhD, BCBA-D Association for Science in Autism Treatment David: I learned of Autism New Jersey (formerly COSAC) in the late 1980s and have seen it grow steadily in size and impact over the last 30 years. How would you describe Autism New Jersey to our readers? Suzanne: Autism New Jersey (ANJ) is a…
EXECUTIVE DIRECTOR David Celiberti, PhD, BCBA-D, is the part time Executive Director of ASAT and Past-President, a role he served from 2006 and 2012. He is the Co-Editor of ASAT’s newsletter, Science in Autism Treatment… Read moreHe received his PhD in clinical psychology from Rutgers University in 1993. Dr. Celiberti has served on a number of…
Fiske, K. E. (2017). Autism and the family: Understanding and supporting families and siblings. New York, NY: W. W. Norton & Company, Inc. Reviewed by David Celiberti, PhD, BCBA-D and May Chrisline Beaubrun, MEd, BCBA Association for Science in Autism Treatment The critical role of the family cannot be understated when providing services to…
An Interview with Dr. Stephen Eversole Founder and owner of Behavior Development Solutions. David Celiberti, PhD, BCBA-D Association for Science in Autism Treatment I recently had the opportunity to speak with Dr. Stephen Eversole, founder and owner of Behavior Development Solutions. David: Stephen, thank you so much for taking the time to participate in this…
Kate McKenna, M.Ed, M.S.Ed, BCBA, LBA Association for Science in Autism Treatment May was auction month at ASAT and this, our 9th Annual Autism Awareness Campaign & Auction was our most successful to date! Thanks to all of you who participated in the 2019 auction on Bidding for Good we raised over $11,000 that will…
Blanco, S., & Demiri, V. (2017). ABA tools of the trade: Easy data collection for the classroom. New York, NY: Different Roads to Learning. Reviewed by Karrie Lindeman, EdD, BCBA-D, LBA and David Celiberti, PhD, BCBA-D Association for Science in Autism Treatment ABA Tools of the Trade Data collection is the core of the success of…